Should you support your children at university or help them on to property ladder?

What parents should consider before making a financial decision

MRK May 2024 120.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0600

0.0000

(0.00%)

As of 01:35PM EDT. Market open.

Loading interactive chart…

Business Wire
Merck to Acquire EyeBio
RAHWAY, N.J. & NEW YORK, May 29, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.
Reuters
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Merck has said it's in the market for deals of up to around $15 billion as it plans ways to deal with a loss of revenue from its aging cancer immunotherapy Keytruda.
Investing.com
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.